logo
logo

 Broncus Holding Company Closes Series C Financing

Oct 14, 2020over 4 years ago

Round Type

series c

Hangzhou

Description

Broncus Holding Company (“Broncus”), a global leader in diagnostic and therapeutic technology for lung diseases, today announced the closing of a Series C round of funding led by Lake Bleu Capital, and including Baidu Capital, the venture arm of one of the world’s largest Internet and data science companies, Ascendum Capital, CNCB Capital and DCP Capital, along with previous investor Qiming Venture Capital.

Company Information

Company

Broncus Holding Company

Location

Hangzhou, Zhejiang, China

About

Broncus is dedicated to the development of diagnostic and therapeutic technology for lung disease. Founded in 2012, the company’s primary technology platforms focus on the diagnosis of lung cancer and the treatment of emphysema. Its lung cancer portfolio includes the Archimedes® System, Archimedes® Planner, LungPoint® Virtual Bronchoscopic Navigation (VBN) System, LungPoint® Planner and FleXNeedle®.

FundzWatch™ Score

70
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood